Twist Bioscience Corp (TWST)
40.27
-2.20
(-5.18%)
USD |
NASDAQ |
Nov 14, 13:00
Twist Bioscience Free Cash Flow: -74.94M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
June 30, 2024 | -74.94M |
March 31, 2024 | -95.52M |
December 31, 2023 | -128.84M |
September 30, 2023 | -170.25M |
June 30, 2023 | -164.88M |
March 31, 2023 | -211.73M |
December 31, 2022 | -232.70M |
September 30, 2022 | -226.24M |
June 30, 2022 | -251.40M |
March 31, 2022 | -211.54M |
December 31, 2021 | -170.18M |
September 30, 2021 | -139.30M |
Date | Value |
---|---|
June 30, 2021 | -123.84M |
March 31, 2021 | -115.25M |
December 31, 2020 | -143.71M |
September 30, 2020 | -152.12M |
June 30, 2020 | -151.95M |
March 31, 2020 | -152.88M |
December 31, 2019 | -116.06M |
September 30, 2019 | -102.69M |
June 30, 2019 | -93.19M |
March 31, 2019 | -83.50M |
December 31, 2018 | -75.93M |
September 30, 2018 | -69.85M |
Free Cash Flow Range, Past 5 Years
-251.40M
Minimum
Jun 2022
-74.94M
Maximum
Jun 2024
-159.65M
Average
-152.12M
Median
Sep 2020
Free Cash Flow Benchmarks
Perspective Therapeutics Inc | -24.58M |
Retractable Technologies Inc | 4.325M |
InfuSystems Holdings Inc | 2.464M |
Xtant Medical Holdings Inc | -17.52M |
Catheter Precision Inc | -7.444M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -6.378M |
Cash from Investing (Quarterly) | -0.711M |
Cash from Financing (Quarterly) | 2.908M |
Free Cash Flow Per Share (Quarterly) | -0.1263 |
Free Cash Flow to Equity (Quarterly) | -7.343M |
Free Cash Flow to Firm (Quarterly) | -7.343M |
Free Cash Flow Yield | -3.23% |